Filter
231 - 240 of 588 results
Results for
Abt Receives USAID Award to Strengthen Tuberculosis Control in Uzbekistan
News
The U.S. Agency for International Development awarded an Abt Global team a project to continue Abt’s work to reduce tuberculosis cases in Uzbekistan.
Abt Global Gathers the Data to Back Need for COVID Booster Shots and Other Critical CDC Decisions
News
Abt Global provides the CDC key data for critical decisions, from recommending booster shots to informing masking recommendations.
Project Roomkey Helped Vulnerable, Homeless Californians at COVID’s Peak — and Continues To Serve As an Effective Emergency Housing Model
News
Abt’s evaluation found California’s Project Roomkey helped homeless Californians at COVID’s peak — and it could serve as an effective emergency housing model.
New Study Raises Questions About Benefits of Text Messaging to Increase College Enrollment Among Low-Income Students
News
A new study on the Department of Education’s GEAR UP program calls into question the benefits of using text messaging to encourage low-income college students.
Abt Global Joins the Massachusetts Business Coalition for Early Childhood Education as a Founding Member
News
Abt is a founding member of the Massachusetts Business Coalition for Early Childhood Education, which promotes best practices to advance equitable child care.
Bureau of Justice Statistics Releases Correctional Data Collected by Abt Global
News
Abt Global Acquires TSPi, Expanding Digital Capabilities and Expertise to Accelerate Client Success
News
Acquisition of TSPi brings new digital solutions across the full client lifecycle.
HRSA, Abt Team To Explore How Systems Changes Influence Early Childhood and Families
News
Abt will evaluate HRSA’s Early Childhood Comprehensive Systems Health Integration P-3 Program to understand how program changes affect equitable outcomes.
Abt to Help CDC Prepare for the Next Global Health Emergency
News
CDC awarded an Abt Global-led team a contract to help prepare needed information in advance of the next public health emergency.
Study Shows Pfizer Vaccine Is Moderately Effective Against Omicron for Children 5-15
News
A new CDC-Abt study using real-world data shows that the Pfizer-BioNTech COVID-19 vaccine is moderately effective for children ages 5-15.